Concordas, Mitchelee B.

HRN: 29-06-42  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2026
CEFUROXIME 750MG (VIAL)
05/27/2026
06/03/2026
IV
750 Mg
Q 8
UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines